Skip to content
Open access

1Hz vs. cTBS Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics: A Randomized Clinical Trial

Oct 2026 · medRxiv · 0 citations · 50 references
Medicine

TL;DR

SMA-directed cTBS is a safe, feasible augmentation that may amplify the neural effects of CBIT on sensorimotor circuitry and identify cTBS as the preferred stimulation regimen for future efficacy testing.

Abstract

Background: Response to Comprehensive Behavioral Intervention for Tics (CBIT), the first-line treatment for tic disorders, is suboptimal. We conducted Phase 1 of a two-phase, milestone-driven trial to determine if augmenting CBIT with repetitive transcranial magnetic stimulation (TMS) to supplementary motor area (SMA) could safely engage targeted sensorimotor circuitry and improve tic controllability. Methods: In a 3-arm, double-blind, sham-controlled randomized trial (NCT04578912), 50 youth (ages 12-21) with moderate-to-severe tics received 10 sessions of either 1Hz rTMS, continuous theta burst stimulation (cTBS), or sham stimulation to the SMA, immediately followed by CBIT. Primary outcomes were safety, feasibility, and neural target engagement (fMRI SMA activation and resting-state functional connectivity [RSFC]). Secondary outcomes included change in tic controllability, tic frequency at rest, and urges. Results: The CBIT+TMS intervention was safe and feasible (96% completion). Treatment-related adverse events were mild-to-moderate and occurred more frequently in the 1Hz rTMS group (27% of sessions) vs. cTBS (14.7%) and sham (11.3%). While task-based SMA activation remained unchanged, cTBS demonstrated robust neural target engagement, reducing SMA-primary motor cortex (M1) RSFC and putamen-M1 RSFC. Conversely, 1Hz rTMS blunted the cortico-striatal connectivity reductions observed in the sham group. All groups exhibited significant reductions in tic frequency and improved controllability. Premonitory urges increased in the 1Hz rTMS group but decreased in sham and cTBS. Conclusions: SMA-directed cTBS is a safe, feasible augmentation that may amplify the neural effects of CBIT on sensorimotor circuitry. Findings identify cTBS as the preferred stimulation regimen for future efficacy testing. Clinical Trial Registration: ClinicalTrials.gov; Identifier: NCT04578912.

Read PDF

Similar papers

Oct 2026

Safety and feasibility of accelerated deep transcranial magnetic stimulation for stimulant use disorder: A pilot study.

BACKGROUND Stimulant use disorder (StUD) remains a major public health concern with limited treatment options and high attrition. Deep transcranial magnetic stimulation (dTMS) targeting the medial prefrontal and anterior cingulate cortices may modulate circuits involved in craving and control. This pilot study evaluate...

Maxime Richard, E. Bousseau, Véronique Desbeaumes Jodoin et al. · 0 citations
Open access Oct 2026

High-Intensity Transcranial Alternating Current Stimulation for Post-Stroke Cognitive Impairment: A Triple-Blind Randomized Trial.

Hi-tACS improved global cognition and working memory in patients with PSCI and was generally well tolerated, and as a broad-network stimulation approach may reduce reliance on selecting a single precise target, a potential practical advantage in heterogeneous PSCI.

Yi-Nan Ai, Shu-Xian Zhang, Li Huang et al. · 0 citations
Open access Oct 2026

Movement-specific effects of transcranial magnetic stimulation over premotor and parietal cortices after stroke

Background: Transcranial magnetic stimulation (TMS) has been proposed to support post-stroke motor recovery, but the response may depend on the task and motor-network status. We aimed to compare how premotor and parietal stimulation affects performance across reach directions with different movement demands, in prepara...

G. Haddadshargh, R. D. de Freitas, J. Mak et al. · 0 citations
Open access Oct 2026

Theta-band EEG changes following sequential rTMS and tACS in fibromyalgia: A randomized controlled pilot study

Background: Sequential application of repetitive transcranial magnetic stimulation (rTMS) and transcranial alternating current stimulation (tACS) may induce neurophysiological changes within sensorimotor and pain-related networks. However, the resting-state EEG effects of this combined approach in fibromyalgia remain u...

O. Buráň, B. R. Sani, D. Cabello et al. · 0 citations
Sep 2026

Connectivity- and frequency-individualized accelerated intermittent theta burst stimulation in treatment-resistant depression: A randomized controlled trial.

Accelerated intermittent theta burst stimulation (aiTBS) is an effective neuromodulatory intervention for treatment resistant depression (TRD). aiTBS delivers repetitive transcranial magnetic stimulation sessions over a compressed timeframe and can be individualized to specific locations using resting-state functional...

L. Appelbaum, Louise A. Stolz, Yin-Ming Sun et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.